Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 3/20 | 0.38 |
| ▸ | EHMT2 | Q96KQ7 | 3/20 | 0.38 |
| ▸ | RCOR1 | Q9UKL0 | 3/20 | 0.38 |
| ▸ | BCDIN3D | Q7Z5W3 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HTR7 | P34969 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2812174 | 0.92 | LMNA (0.51) | LMNAKDM1AEHMT2RCOR1MEN1 | |
| SCHEMBL537948 | 0.89 | KDM1A (0.46) | KDM1AEHMT2RCOR1SIGMAR1 | |
| SCHEMBL2811945 | 0.87 | ACHE (0.38) | LMNAACHEMEN1KMT2A | |
| SCHEMBL2814505 | 0.86 | KDM1A (0.46) | LMNAKDM1AEHMT2RCOR1SIGMAR1 | |
| SCHEMBL537894 | 0.85 | ALDH1A1 (0.38) | LMNAKDM1AEHMT2RCOR1 | |
| SCHEMBL2808425 | 0.84 | MRGPRX1 (0.39) | SIGMAR1HTR7 | |
| SCHEMBL2812009 | 0.84 | ALDH1A1 (0.38) | MAOBSIGMAR1MEN1KMT2AHTR7 | |
| SCHEMBL2810531 | 0.84 | MRGPRX1 (0.48) | MEN1KMT2A | |
| SCHEMBL2814891 | 0.83 | HRH2 (0.41) | BCDIN3DSIGMAR1 | |
| SCHEMBL2812003 | 0.83 | KDM1A (0.47) | KDM1AEHMT2RCOR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8343983-B2 | Substituted pyrazolo-pyrimidine compounds | ARQULE, INC. (US) | 2013-01-01 | — | — | US | disclosed |
| US-20100249110-A1 | SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS | ARQULE, INC. (US) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249110-A1 | SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS | DPYD, TYMP, TP53 | LMNA 2815/4885KDM1A 3360/4885EHMT2 3441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.